Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
SB

SBIOETF / FundALPS Medical Breakthroughs ETF

$53.53 last close 2026-11-17
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment SBIO's does — no target price to set, unlike a price alert.

Sharia status
NOT COMPLIANT
Screened by look-through to its filed holdings — 47% of portfolio weight covered
Fund look-through

ALPS Medical Breakthroughs ETF ETF · ALPS ETF TRUST

110 holdings · as of 2026-08-31 (2.6 months ago)

NON-COMPLIANT At least 34.89% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 53% turns out to be. Matching more holdings can only raise this share, never lower it.

110 holdings, 72 matched (47% of weight). Portfolio as of 2026-08-31, filed 2026-10-29. Source: SEC Form N-PORT.

11.19% of this portfolio’s income is non-permissible — weighted across holdings, computed over 28% of portfolio weight (36 of 110 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.

Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.

All holdings (110)
HoldingStatusWeightEvery methodology, and the debt ratio behind it
Crinetics Pharmaceuticals Inc UNSCREENED 4.60% no in-house ratios for this holding
Apogee Therapeutics Inc UNSCREENED 4.29% no in-house ratios for this holding
Cg Oncology Inc UNSCREENED 3.41% no in-house ratios for this holding
TVTX Travere Therapeutics Inc COMPLIANT 3.16% AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4%
Xenon Pharmaceuticals Inc UNSCREENED 2.99% no in-house ratios for this holding
Dianthus Therapeutics Inc UNSCREENED 2.96% no in-house ratios for this holding
Oruka Therapeutics Inc UNSCREENED 2.87% no in-house ratios for this holding
ACAD Acadia Pharmaceuticals Inc COMPLIANT 2.54% AAOIFI2.3% Usmani4.0% Dow Jones Islamic1.9% S&P Shariah2.0% MSCI Islamic4.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
Edgewise Therapeutics Inc UNSCREENED 2.31% no in-house ratios for this holding
Definium Therapeutics Inc UNSCREENED 2.23% no in-house ratios for this holding
DYN Dyne Therapeutics Inc NON_COMPLIANT 2.16% AAOIFI7.0% Usmani17.7% Dow Jones Islamic9.1% S&P Shariah9.1% MSCI Islamic17.7% MSCI Islamic M-Series9.1% FTSE Shariah16.2%
Veradermics Inc UNSCREENED 2.11% no in-house ratios for this holding
Relay Therapeutics Inc UNSCREENED 2.05% no in-house ratios for this holding
Denali Therapeutics Inc UNSCREENED 1.94% no in-house ratios for this holding
Amylyx Pharmaceuticals Inc UNSCREENED 1.93% no in-house ratios for this holding
IDYA Ideaya Biosciences Inc NON_COMPLIANT 1.81% AAOIFI1.0% Usmani2.4% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.4% MSCI Islamic M-Series1.1% FTSE Shariah0.0%
GPCR Structure Therapeutics Inc NON_COMPLIANT 1.68% AAOIFI0.5% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
TARS Tarsus Pharmaceuticals Inc COMPLIANT 1.64% AAOIFI2.3% Usmani14.5% Dow Jones Islamic3.8% S&P Shariah4.7% MSCI Islamic14.5% MSCI Islamic M-Series4.7% FTSE Shariah11.9%
Celldex Therapeutics Inc UNSCREENED 1.60% no in-house ratios for this holding
IMNM Immunome Inc NON_COMPLIANT 1.60% AAOIFI0.5% Usmani2.3% Dow Jones Islamic0.7% S&P Shariah0.9% MSCI Islamic2.3% MSCI Islamic M-Series0.9% FTSE Shariah0.0%
Disc Medicine Inc UNSCREENED 1.54% no in-house ratios for this holding
Newamsterdam Pharma Co Nv UNSCREENED 1.52% no in-house ratios for this holding
Mbx Biosciences Inc UNSCREENED 1.50% no in-house ratios for this holding
9688.HK Zai Lab Ltd NON_COMPLIANT 1.42% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
Viridian Therapeutics Inc UNSCREENED 1.31% no in-house ratios for this holding
Sellas Life Sciences Group Inc UNSCREENED 1.28% no in-house ratios for this holding
BCRX Biocryst Pharmaceuticals Inc NON_COMPLIANT 1.27% AAOIFI21.1% Usmani68.8% Dow Jones Islamic21.3% S&P Shariah23.8% MSCI Islamic68.5% MSCI Islamic M-Series23.8% FTSE Shariah66.9%
Vera Therapeutics Inc UNSCREENED 1.26% no in-house ratios for this holding
NKTR Nektar Therapeutics NON_COMPLIANT 1.24% AAOIFI6.0% Usmani7.1% Dow Jones Islamic6.7% S&P Shariah9.2% MSCI Islamic7.1% MSCI Islamic M-Series9.2% FTSE Shariah0.0%
Rapport Therapeutics Inc UNSCREENED 1.19% no in-house ratios for this holding
NUVB Nuvation Bio Inc NON_COMPLIANT 1.19% AAOIFI21.7% Usmani38.6% Dow Jones Islamic20.6% S&P Shariah25.7% MSCI Islamic38.6% MSCI Islamic M-Series25.7% FTSE Shariah36.7%
Mineralys Therapeutics Inc UNSCREENED 1.16% no in-house ratios for this holding
SRPT Sarepta Therapeutics Inc NON_COMPLIANT 1.14% AAOIFI43.1% Usmani32.8% Dow Jones Islamic21.4% S&P Shariah14.9% MSCI Islamic32.8% MSCI Islamic M-Series14.9% FTSE Shariah26.6%
Palvella Therapeutics Inc UNSCREENED 1.12% no in-house ratios for this holding
ZBIO Zenas Biopharma Inc NON_COMPLIANT 1.05% AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2%
VCEL Vericel Corp COMPLIANT 1.05% AAOIFI4.0% Usmani18.5% Dow Jones Islamic4.4% S&P Shariah4.4% MSCI Islamic18.4% MSCI Islamic M-Series4.4% FTSE Shariah0.0%
Xencor Inc UNSCREENED 1.04% no in-house ratios for this holding
AGIO Agios Pharmaceuticals Inc NON_COMPLIANT 1.03% AAOIFI1.4% Usmani2.5% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic2.5% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
KLRA Kailera Therapeutics Inc NON_COMPLIANT 1.03% AAOIFI0.6% Usmani0.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.9% MSCI Islamic M-Series— FTSE Shariah0.0%
Generate Biomedicines Inc UNSCREENED 1.00% no in-house ratios for this holding
STOK Stoke Therapeutics Inc NON_COMPLIANT 1.00% AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
LKFT.AS Lakefront Biotherapeutics Nv NON_COMPLIANT 0.95% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
IMCR Immunocore Holdings Plc NON_COMPLIANT 0.95% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
CMPS Compass Pathways Plc NON_COMPLIANT 0.94% AAOIFI4.3% Usmani10.5% Dow Jones Islamic6.8% S&P Shariah7.7% MSCI Islamic10.5% MSCI Islamic M-Series7.7% FTSE Shariah9.8%
TSHA Taysha Gene Therapies Inc NON_COMPLIANT 0.84% AAOIFI3.9% Usmani12.5% Dow Jones Islamic5.1% S&P Shariah6.4% MSCI Islamic12.5% MSCI Islamic M-Series6.4% FTSE Shariah10.9%
BCAX Bicara Therapeutics Inc NON_COMPLIANT 0.78% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.2% MSCI Islamic M-Series— FTSE Shariah0.0%
TYRA Tyra Biosciences Inc COMPLIANT 0.77% AAOIFI0.4% Usmani0.8% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.8% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
MAZE Maze Therapeutics Inc COMPLIANT 0.76% AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6%
AVBP Arrivent Biopharma Inc NON_COMPLIANT 0.72% AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
LBRX Lb Pharmaceuticals Inc NON_COMPLIANT 0.70% AAOIFI0.4% Usmani1.1% Dow Jones Islamic— S&P Shariah— MSCI Islamic1.1% MSCI Islamic M-Series— FTSE Shariah0.0%
IMTX Immatics Nv NON_COMPLIANT 0.66% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
MGTX Meiragtx Holdings Plc COMPLIANT 0.65% AAOIFI1.4% Usmani2.9% Dow Jones Islamic1.6% S&P Shariah2.0% MSCI Islamic2.9% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
Seaport Therapeutics Inc UNSCREENED 0.65% no in-house ratios for this holding
Alto Neuroscience Inc UNSCREENED 0.64% no in-house ratios for this holding
MNKD Mannkind Corp NON_COMPLIANT 0.64% AAOIFI25.3% Usmani45.8% Dow Jones Islamic23.8% S&P Shariah24.2% MSCI Islamic45.8% MSCI Islamic M-Series24.2% FTSE Shariah44.2%
VOR Vor Biopharma Inc NON_COMPLIANT 0.62% AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic0.6% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
CRVS Corvus Pharmaceuticals Inc COMPLIANT 0.61% AAOIFI0.1% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
KURA Kura Oncology Inc NON_COMPLIANT 0.58% AAOIFI3.8% Usmani4.6% Dow Jones Islamic3.4% S&P Shariah2.6% MSCI Islamic4.6% MSCI Islamic M-Series2.6% FTSE Shariah1.7%
CADL Candel Therapeutics Inc NON_COMPLIANT 0.49% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
GERN Geron Corp NON_COMPLIANT 0.49% AAOIFI20.0% Usmani23.0% Dow Jones Islamic11.6% S&P Shariah8.9% MSCI Islamic23.0% MSCI Islamic M-Series8.9% FTSE Shariah22.8%
Solid Biosciences Inc UNSCREENED 0.49% no in-house ratios for this holding
DSGN Design Therapeutics Inc NON_COMPLIANT 0.49% AAOIFI0.4% Usmani1.2% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic1.2% MSCI Islamic M-Series0.6% FTSE Shariah0.0%
WVE Wave Life Sciences Inc NON_COMPLIANT 0.48% AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0%
OLMA Olema Pharmaceuticals Inc NON_COMPLIANT 0.47% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
Theravance Biopharma Inc UNSCREENED 0.45% no in-house ratios for this holding
RIGL Rigel Pharmaceuticals Inc COMPLIANT 0.44% AAOIFI5.0% Usmani8.8% Dow Jones Islamic9.0% S&P Shariah11.3% MSCI Islamic8.8% MSCI Islamic M-Series11.3% FTSE Shariah8.6%
ACRS Aclaris Therapeutics Inc NON_COMPLIANT 0.44% AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.6% MSCI Islamic0.8% MSCI Islamic M-Series0.6% FTSE Shariah0.0%
Spyglass Pharma Inc UNSCREENED 0.43% no in-house ratios for this holding
CLYM Climb Bio Inc NON_COMPLIANT 0.41% AAOIFI0.2% Usmani0.5% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.5% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
FDMT 4d Molecular Therapeutics Inc NON_COMPLIANT 0.38% AAOIFI6.2% Usmani9.0% Dow Jones Islamic9.4% S&P Shariah6.5% MSCI Islamic9.0% MSCI Islamic M-Series6.5% FTSE Shariah4.6%
OCSAW Oculis Holding Ag NON_COMPLIANT 0.36% AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0%
ALLO Allogene Therapeutics Inc NON_COMPLIANT 0.36% AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0%
Agomab Therapeutics Nv UNSCREENED 0.33% no in-house ratios for this holding
ALT Altimmune Inc NON_COMPLIANT 0.31% AAOIFI11.3% Usmani7.3% Dow Jones Islamic7.7% S&P Shariah7.6% MSCI Islamic7.3% MSCI Islamic M-Series7.6% FTSE Shariah7.1%
NGNE Neurogene Inc NON_COMPLIANT 0.30% AAOIFI1.6% Usmani2.0% Dow Jones Islamic2.0% S&P Shariah2.0% MSCI Islamic2.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
DCTH Delcath Systems Inc COMPLIANT 0.29% AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
EIKN Eikon Therapeutics Inc NON_COMPLIANT 0.29% AAOIFI85.5% Usmani35.3% Dow Jones Islamic— S&P Shariah— MSCI Islamic35.3% MSCI Islamic M-Series— FTSE Shariah0.0%
TECX Tectonic Therapeutic Inc NON_COMPLIANT 0.29% AAOIFI0.7% Usmani1.9% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.8% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
FLGT Fulgent Genetics Inc NON_COMPLIANT 0.28% AAOIFI1.2% Usmani0.8% Dow Jones Islamic1.4% S&P Shariah1.3% MSCI Islamic0.8% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
CTNM Contineum Therapeutics Inc NON_COMPLIANT 0.27% AAOIFI1.7% Usmani2.4% Dow Jones Islamic2.5% S&P Shariah2.3% MSCI Islamic2.4% MSCI Islamic M-Series2.3% FTSE Shariah0.0%
Zura Bio Ltd UNSCREENED 0.27% no in-house ratios for this holding
RLMD Relmada Therapeutics Inc NON_COMPLIANT 0.24% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
EVMN Evommune Inc NON_COMPLIANT 0.24% AAOIFI2.5% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.7% MSCI Islamic M-Seriesfail FTSE Shariah0.0%
Rezolute Inc UNSCREENED 0.23% no in-house ratios for this holding
CMPX Compass Therapeutics Inc NON_COMPLIANT 0.22% AAOIFI7.8% Usmani5.3% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic5.3% MSCI Islamic M-Series2.3% FTSE Shariah0.0%
ARCT Arcturus Therapeutics Holdings Inc NON_COMPLIANT 0.22% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
CCCC C4 Therapeutics Inc NON_COMPLIANT 0.21% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
Enanta Pharmaceuticals Inc UNSCREENED 0.20% no in-house ratios for this holding
XFOR X4 Pharmaceuticals Inc NON_COMPLIANT 0.20% AAOIFI20.0% Usmani29.8% Dow Jones Islamic10.3% S&P Shariah5.3% MSCI Islamic29.8% MSCI Islamic M-Series5.3% FTSE Shariah29.6%
UPB Upstream Bio Inc NON_COMPLIANT 0.19% AAOIFI0.4% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0%
Immuneering Corp UNSCREENED 0.17% no in-house ratios for this holding
IKT Inhibikase Therapeutics Inc NON_COMPLIANT 0.16% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
SABS Sab Biotherapeutics Inc NON_COMPLIANT 0.15% AAOIFI0.6% Usmani2.2% Dow Jones Islamic1.8% S&P Shariah2.3% MSCI Islamic0.8% MSCI Islamic M-Series2.3% FTSE Shariah0.0%
SION Sionna Therapeutics Inc NON_COMPLIANT 0.14% AAOIFI5.1% Usmani2.9% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic2.9% MSCI Islamic M-Series— FTSE Shariah0.0%
Anavex Life Sciences Corp UNSCREENED 0.13% no in-house ratios for this holding
FULC Fulcrum Therapeutics Inc NON_COMPLIANT 0.13% AAOIFI2.4% Usmani2.2% Dow Jones Islamic1.9% S&P Shariah1.8% MSCI Islamic2.2% MSCI Islamic M-Series1.8% FTSE Shariah0.0%
MGNX Macrogenics Inc NON_COMPLIANT 0.13% AAOIFI26.6% Usmani10.9% Dow Jones Islamic21.5% S&P Shariah12.1% MSCI Islamic10.9% MSCI Islamic M-Series12.1% FTSE Shariah0.0%
AKBA Akebia Therapeutics Inc NON_COMPLIANT 0.13% AAOIFI45.9% Usmani17.7% Dow Jones Islamic12.5% S&P Shariah14.6% MSCI Islamic17.7% MSCI Islamic M-Series14.6% FTSE Shariah14.7%
TARA Protara Therapeutics Inc NON_COMPLIANT 0.11% AAOIFI1.6% Usmani1.6% Dow Jones Islamic1.4% S&P Shariah1.8% MSCI Islamic1.6% MSCI Islamic M-Series1.8% FTSE Shariah0.0%
IMUX Immunic Inc NON_COMPLIANT 0.11% AAOIFI0.6% Usmani0.4% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.4% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
NBP Novabridge Biosciences NON_COMPLIANT 0.11% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
50BA.SG Bicycle Therapeutics Plc NON_COMPLIANT 0.11% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
TENX Tenax Therapeutics Inc NON_COMPLIANT 0.03% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
State Street Institutional Treasury Plus Money Market Fund UNSCREENED 0.02% no in-house ratios for this holding
NOVO-B.CO Novo Nordisk A/s COMPLIANT 0.00% AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass
AZN Astrazeneca Plc COMPLIANT 0.00% AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah—
Chinook Therapeutics Inc UNSCREENED 0.00% no in-house ratios for this holding
OABI Omniab Inc NON_COMPLIANT 0.00% AAOIFI2.5% Usmani6.2% Dow Jones Islamic5.3% S&P Shariah4.4% MSCI Islamic6.2% MSCI Islamic M-Series4.4% FTSE Shariah0.0%
OABI Omniab Inc NON_COMPLIANT 0.00% AAOIFI2.5% Usmani6.2% Dow Jones Islamic5.3% S&P Shariah4.4% MSCI Islamic6.2% MSCI Islamic M-Series4.4% FTSE Shariah0.0%
N/A UNSCREENED 0.00% no in-house ratios for this holding

The published standards disagree about this fund by 13 points of portfolio weight — 13.2% of it passes S&P Shariah, 0.6% passes MSCI Islamic. Which number is yours depends on which standard you follow.

These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.

ratios pass on 10.8% ratios fail on 32.5% 56.7% not rated under AAOIFI

71 of 110 listed holdings carry our own per-methodology verdicts (47% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 59 (42% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.

Non-compliant holdingWeight
DYN Dyne Therapeutics Inc 2.16%
IDYA Ideaya Biosciences Inc 1.81%
GPCR Structure Therapeutics Inc 1.68%
IMNM Immunome Inc 1.60%
9688.HK Zai Lab Ltd 1.42%
BCRX Biocryst Pharmaceuticals Inc 1.27%
NKTR Nektar Therapeutics 1.24%
NUVB Nuvation Bio Inc 1.19%
SRPT Sarepta Therapeutics Inc 1.14%
ZBIO Zenas Biopharma Inc 1.05%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 4 timeframes bullish · 11.8% aligned
VWAPPrice below VWAP ($55.42)
VolumeRelative volume 3.9× the 20-day average
Momentum10-day rate of change -1.5%

ALPS Medical Breakthroughs ETF (SBIO) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.

Market & analysts
Momentum (10d)
-1.5%
rate of change
SMC grade
D · 38
11.8% aligned
D · 38
SMC grade — 11.8% timeframe alignment
-1.5%
Rate of change (10d)

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for SBIO — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding SBIO
InvestorFirmPositionWeightAs of
Ken Griffin Citadel Advisors $1M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

70.7964.6158.4452.2646.082025-11-182026-05-202026-11-17

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
51.24
S2
52.54
S1
53.20
PIVOT
54.50
R1
55.16
R2
56.46
R3
57.12

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
59.62 – 67.80
±6.43% from 63.71, made 2026-09-15 · resolves 2026-09-22
SELL
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsBUY
3 buy · 2 neutral · 2 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)43.30NEUTRAL
Stochastic %K (14)12.96BUY
CCI (20)-88.91NEUTRAL
Williams %R (14)-87.04BUY
MACD (12,26,9)0.06BUY
ROC (10)-1.54SELL
Momentum (10)-0.84SELL
EMA (10)55.22SELL
SMA (10)55.68SELL
EMA (20)55.31SELL
SMA (20)55.17SELL
EMA (30)55.76SELL
SMA (30)54.41SELL
EMA (50)56.98SELL
SMA (50)56.77SELL
EMA (100)58.20SELL
SMA (100)61.59SELL
EMA (200)56.00SELL
SMA (200)57.23SELL

About ALPS Medical Breakthroughs ETF

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 42
🕐 1H RANGING 51
⏱ 15-Min BEARISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-1.5%
Rate of change (10d)
3.9×
Volume vs its 20-day average
-0.23
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is a fund screened on its name?

No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.

What does unrated weight mean?

It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.

Does the issuer's board make it compliant?

It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.

How often is this re-screened?

When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.